DNA X (formerly Sonim Technologies) is an early-stage cryptocurrency trading platform. The company operates dnax.us, a web-based platform where individual crypto traders can buy, sell, and swap cryptocurrencies. DNA X's core feature is automated trading strategies: users can set price-ratio triggers to automatically buy or sell one cryptocurrency relative to another, capturing profits as prices move within a range. These strategies are publicly visible, can be copied by other users, and come with historical performance data. DNA X does not take custody of customer assets — users retain ownership throughout, and commissions are automatically deducted from each trade. DNA X earns revenue on a per-trade commission basis, meaning revenue scales directly with trading volume. The company keeps its cost structure lean by licensing third-party software and relying on contractors, which DNA X argues allows it to charge lower fees than larger competitors. The platform is currently operating on a limited basis with minimal marketing, relying primarily on word of mouth for growth. DNA X is also developing crypto lending and staking features to generate additional fee streams, and plans to list more cryptocurrencies to broaden user appeal. The company has only four full-time employees and four contractors.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →